Effects of intravenous ondansetrion on preventing hypotension after induction of anesthesia in eldery patients: A randomized placebo controlled clinical trial

Effects of intravenous ondansetrion on preventing hypotension after induction of anesthesia in eldery patients: A randomized placebo controlled clinical trial - Ondansetron for prevention of hypotension

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013466

Enrollment

120

Registered

2014-06-01

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ondensetron&#39

Interventions

Intravenous Ondansetron 0.05 mg/kg Equivalent volume of normal saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Older than 65 years ASA I, II

Exclusion criteria

Exclusion criteria: Sensitivity to ondansetron Resting bradycardia (< 60 bpm) History of SSRI usage Congestive Heart Failure

Design outcomes

Primary

Measure	Time frame
rates of hypotention after induction of general anesthesia	—

Countries

Asia(except Japan)

Contacts

Public ContactMahmoud Saghaei

Isfahan University of Medical Sciences Department of Anesthesia

mahmood.saghaei@gmail.com+81-983116249031

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026